Why has the scientific community failed to develop a prevention treatment for PKD (polycystic kidney disease)? - polycystic kidney disease breakthroughs
because so many Americans, and any prophylactic treatment should be administered through the rest of the life of a patient, it would be very useful for big pharma.
In addition, we also know that the genetic mutation is responsible for ensuring that the ERP ...
What are the difficulties when trying to develop a strategy for ERP treatment develop?
is the rise of genomics and recombinant DNA techniques, which can lead to a breakthrough?
What is the improvement of access for human totipotent cells for research or therapy? Is it likely to move in search of a cure?
1 comment:
Genetic engineering is a reality that can not so much can be made of this condition.
Post a Comment